You are not wrong about the pre-clinical results being too compelling to ignore!
Taken from the investor presentation (https://hotcopper.com.au/threads/ann-gold-coast-investment-showcase-presentation.6123575/)
(1) The results from the rat model were bananas
(2) This was followed up by a pig model, that more closely reflects human pathology (taken from https://hotcopper.com.au/threads/ann-positive-results-in-glaucoma-pig-model.5276629/)
It looks that EmtinB when injected into a pig (the animal with the pathology most similar to that of a human), showed statistical significance to reduce Glaucoma - at least in those cases that mimic the worst human pathology...
(3) The peptide was modelled off something naturally occurring in our immune systems anyway, is safe, and hits the target
GLTAH
